BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 6538004)

  • 1. Myasthenia gravis: prolonged treatment with steroids.
    Sghirlanzoni A; Peluchetti D; Mantegazza R; Fiacchino F; Cornelio F
    Neurology; 1984 Feb; 34(2):170-4. PubMed ID: 6538004
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-term prednisone followed by thymectomy in myasthenia gravis.
    Mann JD; Johns TR; Campa JF; Muller WH
    Ann N Y Acad Sci; 1976; 274():608-22. PubMed ID: 1066998
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Corticotropin and corticosteroids in generalized myasthenia gravis: comparative studies and role in management.
    Brunner NG; Berger CL; Namba T; Grob D
    Ann N Y Acad Sci; 1976; 274():577-95. PubMed ID: 183590
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term administration of corticosteroids in myasthenia gravis.
    Mann JD; Johns TR; Campa JF
    Neurology; 1976 Aug; 26(8):729-40. PubMed ID: 821005
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Corticosteroids in the treatment of myasthenia gravis. Study of 12 cases with review of the literature].
    Lamartine de Assis J
    Arq Neuropsiquiatr; 1975 Mar; 33(1):33-40. PubMed ID: 1164206
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effective treatment of infantile myasthenia gravis by combined prednisone and thymectomy.
    Sarnat HB; McGarry JD; Lewis JE
    Neurology; 1977 Jun; 27(6):550-3. PubMed ID: 559263
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Randomized Trial of Thymectomy in Myasthenia Gravis.
    Wolfe GI; Kaminski HJ; Aban IB; Minisman G; Kuo HC; Marx A; Ströbel P; Mazia C; Oger J; Cea JG; Heckmann JM; Evoli A; Nix W; Ciafaloni E; Antonini G; Witoonpanich R; King JO; Beydoun SR; Chalk CH; Barboi AC; Amato AA; Shaibani AI; Katirji B; Lecky BR; Buckley C; Vincent A; Dias-Tosta E; Yoshikawa H; Waddington-Cruz M; Pulley MT; Rivner MH; Kostera-Pruszczyk A; Pascuzzi RM; Jackson CE; Garcia Ramos GS; Verschuuren JJ; Massey JM; Kissel JT; Werneck LC; Benatar M; Barohn RJ; Tandan R; Mozaffar T; Conwit R; Odenkirchen J; Sonett JR; Jaretzki A; Newsom-Davis J; Cutter GR;
    N Engl J Med; 2016 Aug; 375(6):511-22. PubMed ID: 27509100
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cellular immune response to acetylcholine receptor in myasthenia gravis: II. Thymectomy and corticosteroids.
    Morgutti M; Conti-Tronconi BM; Sghirlanzoni A; Clementi F
    Neurology; 1979 May; 29(5):734-8. PubMed ID: 571572
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Current views on the treatment of myasthenia gravis: with particular reference to immunological mechanisms.
    Oosterhuis HJ
    Electroencephalogr Clin Neurophysiol Suppl; 1978; (34):555-7. PubMed ID: 285854
    [No Abstract]   [Full Text] [Related]  

  • 10. Experience with starting tacrolimus postoperatively after transsternal extended thymectomy in patients with myasthenia gravis.
    Ponseti JM; Azem J; Fort JM; López-Cano M; Vilallonga R; Gamez J; Armengol M
    Curr Med Res Opin; 2006 May; 22(5):885-95. PubMed ID: 16709310
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Status of the thymectomy trial for nonthymomatous myasthenia gravis patients receiving prednisone.
    Newsom-Davis J; Cutter G; Wolfe GI; Kaminski HJ; Jaretzki A; Minisman G; Aban I; Conwit R
    Ann N Y Acad Sci; 2008; 1132():344-7. PubMed ID: 18567886
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term treatment of myasthenia gravis with alternate-day prednisone. Report on 15 patients.
    Pinelli P; Tonali P; Scoppetta C
    Eur Neurol; 1974; 12(3):129-41. PubMed ID: 4426321
    [No Abstract]   [Full Text] [Related]  

  • 13. Post-thymectomy combined treatment of prednisone and tacrolimus versus prednisone alone for consolidation of complete stable remission in patients with myasthenia gravis: a non-randomized, non-controlled study.
    Ponseti JM; Gamez J; Azem J; Fort JM; López-Cano M; Vilallonga R; Buera M; Armengol M
    Curr Med Res Opin; 2007 Jun; 23(6):1269-78. PubMed ID: 17559724
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High-dose steroids for perioperative management of patients with myasthenia gravis undergoing thymectomy. A preliminary report.
    Bolooki H; Schwartzman RJ
    J Thorac Cardiovasc Surg; 1978 May; 75(5):754-7. PubMed ID: 642573
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Stable remissions in myasthenia gravis.
    Perez MC; Buot WL; Mercado-Danguilan C; Bagabaldo ZG; Renales LD
    Neurology; 1981 Jan; 31(1):32-7. PubMed ID: 7192824
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Humoral immunity in myasthenia gravis: effect of steroids and thymectomy.
    Tindall RS
    Neurology; 1980 May; 30(5):554-7. PubMed ID: 7189263
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Thymectomy for myasthenia gravis in the young adult. Long-term results.
    Clark RE; Marbarger JP; West PN; Spratt JA; Florence JM; Roper CL; Ferguson TB; Weldon CS
    J Thorac Cardiovasc Surg; 1980 Nov; 80(5):696-701. PubMed ID: 7431966
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Thymectomy for myasthenia gravis: evaluation of results in 282 patients.
    de Assis JL; Marchiori PE; Zambon AA; Scaff M
    Rev Hosp Clin Fac Med Sao Paulo; 1992; 47(3):117-20. PubMed ID: 1340583
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term results of corticosteroid therapy in patients with myasthenia gravis.
    Evoli A; Batocchi AP; Palmisani MT; Lo Monaco M; Tonali P
    Eur Neurol; 1992; 32(1):37-43. PubMed ID: 1563453
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Influence of ectopic thymic tissue on clinical outcome following extended thymectomy in generalized seropositive nonthymomatous myasthenia gravis.
    Ponseti JM; Gamez J; Vilallonga R; Ruiz C; Azem J; López-Cano M; Armengol M
    Eur J Cardiothorac Surg; 2008 Nov; 34(5):1062-7. PubMed ID: 18760934
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.